Polycythaemia vera (PV) is a chronic myeloproliferative neoplasm (MPN) characterised by a somatic activating mutation in the JAK2 gene that drives abnormal erythrocytosis, resulting in an abnormal increase in red blood cell mass [1,2]. The gene discussed is JAK2; the disease is acquired polycythemia vera.